These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2602881)
1. [Erythropoietin and dialyzed patients]. Kreis H Rev Prat; 1989 Dec; 39(28):2530-1. PubMed ID: 2602881 [No Abstract] [Full Text] [Related]
2. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin]. Schaefer RM Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139 [No Abstract] [Full Text] [Related]
3. [Erythropoietin, aluminum and renal anemia]. Schaefer M; Heidland A Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300 [No Abstract] [Full Text] [Related]
4. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis. Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556 [No Abstract] [Full Text] [Related]
5. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia. Fujita Y; Inoue S; Horiguchi S; Kuki A Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462 [TBL] [Abstract][Full Text] [Related]
6. [Anemia in the dialyzed patient]. Deray G Soins; 2003 Oct; (679 Suppl):17. PubMed ID: 14621469 [No Abstract] [Full Text] [Related]
7. [Treatment of anemia in chronically dialyzed patients]. Moynot A Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055 [No Abstract] [Full Text] [Related]
8. [Improving the administration of erythropoietin]. Suszko P; Rousseau S; Poite O Soins; 2007 Oct; (719 Suppl):S22-3. PubMed ID: 18050874 [No Abstract] [Full Text] [Related]
9. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Korbet SM Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832 [No Abstract] [Full Text] [Related]
10. rHuEpo-resistant anaemia in haemodialysis patients. Ozono Y; Harada T; Taura K; Kawatomi M; Hara K Nephrol Dial Transplant; 1994; 9(7):872-4. PubMed ID: 7970133 [No Abstract] [Full Text] [Related]
11. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years]. Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809 [TBL] [Abstract][Full Text] [Related]
16. Intensity of hemodialysis and response to erythropoietin. Kotanko P N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371 [No Abstract] [Full Text] [Related]
17. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia. Padovese P; Gallieni M; Galmozzi C; Brancaccio D Lancet; 1990 Jun; 335(8703):1465. PubMed ID: 1972238 [No Abstract] [Full Text] [Related]
18. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials. Sobota JT Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519 [No Abstract] [Full Text] [Related]
19. [Study of various factors that could have an impact on the treatment with erythropoietin of hemodialysis anemia]. Fernández-Gallego J; Ramos B; Ruiz A; Contreras J; Alvarez Bustos G; López de Novales E Nefrologia; 2000; 20(2):164-70. PubMed ID: 10853198 [TBL] [Abstract][Full Text] [Related]
20. [The after effect of r-HuEPO in treating anemic hemodialysis patients]. Chu JQ Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758 [No Abstract] [Full Text] [Related] [Next] [New Search]